10-Q: iAnthus Q2 2025: Asset Sales Boost Cash Amid Losses

iAnthus Capital Holdings reported increased cash from strategic asset divestitures in Q2 2025, despite continued net losses and a worsening working capital deficiency, raising substantial doubt about its going concern.

Summary

• For the three months ended June 30, 2025, revenues decreased by 18.2% to $35.2 million from $43.0 million in the prior year period.
• Net loss for the three months ended June 30, 2025, increased to $18.7 million, up from $9.8 million in the same period last year.
• For the six months ended June 30, 2025, revenues decreased by 13.3% to $73.3 million from $84.6 million in the prior year period.
• Net loss for the six months ended June 30, 2025, was $13.6 million, an improvement from $23.8 million in the prior year period, primarily due to significant gains from asset deconsolidation.
• Cash increased to $23.5 million as of June 30, 2025, from $18.5 million as of December 31, 2024.
• The company completed the sale of certain Arizona assets for approximately $36.5 million, receiving $15.8 million in cash and a $16.5 million secured promissory note.
• The sale of Nevada operations was approved and closed on March 31, 2025, generating $3.5 million in cash and a promissory note for the remainder of the $5.9 million proceeds.
• The company acquired substantially all assets of Cheetah Enterprises, Inc.'s wholesale cannabis business for approximately $3.5 million (fair value of consideration $6.6 million).
• The acquisition of LMS Wellness, Benefit LLC was completed on April 21, 2025, after regulatory approval and legal proceedings.
• A settlement agreement was reached in the Roberts legal matter for $5.5 million, payable in installments through January 2029.
• A settlement agreement was reached with Canaccord Genuity Corp. for $2.0 million, payable in installments through September 2027.

Sentiment

Score: 3

Explanation: While strategic asset divestitures have improved cash flow and reduced debt, the company continues to report significant net losses and a worsening working capital deficiency, leading to substantial doubt about its ability to continue as a going concern. Material weaknesses in internal controls also present a concern.

Positives

• Cash balance increased to $23.5 million as of June 30, 2025, from $18.5 million at December 31, 2024, providing improved liquidity.
• Strategic divestitures of Arizona and Nevada assets generated significant cash proceeds and gains on deconsolidation ($6.3 million from AZ, $5.7 million from NV).
• Long-term debt, net of issuance costs, decreased to $175.9 million as of June 30, 2025, from $182.3 million at December 31, 2024.
• Net cash flow provided by operating activities increased slightly to $6.3 million for the six months ended June 30, 2025, compared to $5.9 million in the prior year.
• The Eastern region (Florida, Maryland, New Jersey, Massachusetts, New York, Illinois, Pennsylvania) showed revenue growth of 2.7% for the three months and 6.4% for the six months ended June 30, 2025.
• Resolution of the Roberts legal matter with a $5.5 million settlement provides clarity on a long-standing contingency.
• Settlement reached with former financial advisor Canaccord Genuity Corp. for $2.0 million resolves another legal proceeding.

Negatives

• The company reported a net loss of $18.7 million for the three months ended June 30, 2025, nearly doubling the $9.8 million loss from the prior year period.
• Overall revenues decreased by 18.2% for the three months and 13.3% for the six months ended June 30, 2025, compared to the prior year periods.
• Gross profit declined by 21.9% for the three months and 7.5% for the six months ended June 30, 2025, compared to the prior year periods.
• The working capital deficiency significantly worsened to $21.1 million as of June 30, 2025, from $0.7 million as of December 31, 2024.
• A credit loss provision of $1.4 million was recorded for the three and six months ended June 30, 2025, related to unpaid promissory notes from the Massachusetts asset sale.
• Harvested plant material in the Eastern region decreased significantly due to timing and Hurricane Milton's impact.
• The company continues to operate under substantial doubt about its ability to continue as a going concern due to persistent losses and working capital deficiency.
• Material weaknesses in disclosure controls and internal control over financial reporting were identified, requiring remediation efforts.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern for at least 12 months from the report date due to significant losses and a working capital deficiency.
• The company's business activities remain illegal under U.S. federal law, classifying marijuana as a Schedule I controlled substance, which could lead to material adverse effects.
• Ongoing legal proceedings, including the Walmer matter and Saloum arbitration, could result in significant liabilities or adverse outcomes.
• The company is subject to limitations of Internal Revenue Code Section 280E, restricting deductible expenses and leading to high effective tax rates.
• The IRS has filed Notices of Federal Tax Liens totaling approximately $39.6 million for the years ended December 31, 2020, and 2021, which the company is actively working to resolve.
• Outstanding debt instruments impose restrictions on operating and financing activities, including incurring additional indebtedness, granting liens, making dividends, issuing shares, or selling assets.
• The company's ability to raise additional capital is uncertain, and there is no assurance such capital will be available on favorable terms, if at all.
• Competitive pressures, particularly in Florida, have led to price compression and lower sales volumes, impacting gross profit.

Future Outlook

Management plans to drive sustainable growth by redirecting resources obtained from recent divestments to growth initiatives in Florida, Maryland, New Jersey, Massachusetts, and New York, while maintaining a retail presence in Mesa, Arizona. The company also aims to reduce outstanding debt obligations. It expects to continue generating positive cash flows from operations in the near future and intends to place less reliance on external financing.

Management Comments

• We have taken the necessary measures to control our discretionary spending and employ capital as efficiently as possible.
• After normalizing for one-time items, we expect total operating expenses to remain consistent over the remainder of 2025 as we continue to employ a disciplined capital allocation approach and continue to closely monitor operating expenditures and discretionary spending.
• We believe that we have funding necessary for us to continue as a going concern, but there can be no assurance that such capital will be available to us on favorable terms, if at all.

Industry Context

The company operates in the U.S. cannabis industry, which faces significant challenges due to the federal illegality of marijuana, classifying it as a Schedule I controlled substance. This status impacts financial operations, including tax treatment under IRC Section 280E, and access to traditional capital markets. The industry is also characterized by intense competition, leading to price compression in certain markets like Florida.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess performance against global benchmarks. However, the company's significant accumulated deficit and ongoing 'going concern' warning indicate financial distress relative to more stable, established companies in regulated industries.
• The high effective tax rate due to IRC Section 280E is a common challenge for U.S. cannabis operators, making direct profitability comparisons with non-cannabis industries difficult without adjusting for this unique tax burden.
• The company's strategy of divesting non-core assets to focus on key growth markets (Florida, Maryland, New Jersey, Massachusetts, New York) is a common approach among multi-state operators (MSOs) seeking to optimize their portfolios and improve capital efficiency in a fragmented and highly regulated market.

Management Changes

Corporate Governance

Legal Proceedings

• Roberts Matter: Settled for $5.5 million, payable in installments through January 2029. Joint Stipulation to Dismiss with prejudice filed and approved.
• Walmer Matter: Amended Notice of Civil Claim filed June 4, 2025, seeking $1.77 million for disputed debentures, $0.44 million + $0.15 million for consultancy agreement breach, and $1.0 million for breach of good faith. Company filed response and counterclaim on July 4, 2025.
• Claim by Former Financial Advisor (Canaccord): Settled for $2.0 million, payable in installments through September 2027. Settlement agreement executed August 8, 2025.
• Saloum Arbitration: Ongoing, claiming breach of a Consulting and Joint Venture Agreement for unpaid consulting fees ($1.0 million to $10.0 million). Arbitration is stayed pending resolution of a Declaratory Judgment Complaint.

Related Party Transactions

• Significant portion of long-term debt ($181.5 million as of June 30, 2025) is held by lenders who became related parties upon the closing of the Recapitalization Transaction.
• Deferred Professional Fees of $3.4 million (as of June 30, 2025) are owed to certain related party lenders, reduced from $9.2 million at December 31, 2024, due to a $5.0 million payment from AZ Transaction proceeds and a $1.0 million reduction by lenders.
• Interest payable of $0.2 million (as of June 30, 2025) on the Senior Secured Bridge Notes is owed to related parties.

Stakeholder Impact

• Shareholders: Experience significant dilution from past share issuances (e.g., Recapitalization Transaction) and face ongoing risk due to the substantial accumulated deficit and going concern doubt. Potential for further dilution if additional capital raises occur.
• Employees: Affected by share-based compensation plans (RSUs) and potential severance arrangements (e.g., former CFO).
• Lenders/Creditors: Are significant stakeholders due to substantial debt holdings, with some being related parties. Recent debt repayments and settlements provide some positive movement, but the going concern warning indicates continued risk.
• Customers: May experience changes in product availability and pricing as the company optimizes its portfolio and focuses on specific markets.
• Suppliers: May face risks related to the company's financial stability and ability to meet obligations, particularly given the working capital deficiency.

Next Steps

• Continue to redirect resources from divestments to growth initiatives in Florida, Maryland, New Jersey, Massachusetts, and New York.
• Maintain a retail presence with one dispensary in Mesa, Arizona.
• Reduce outstanding debt obligations.
• Remediate identified material weaknesses in disclosure controls and internal control over financial reporting, including dedicating additional resources to ITGCs and developing a roadmap to become SOX compliant.
• Actively work to resolve federal tax liens with the Internal Revenue Service.

Key Dates

Recommendation

The company presents a mixed financial picture. Recent asset sales have significantly boosted cash reserves and reduced long-term debt, providing some liquidity. However, persistent net losses, a substantial accumulated deficit, and a worsening working capital deficiency raise serious going concern doubts. The identified material weaknesses in internal controls also warrant caution. While the strategic focus on key markets and resolution of some legal matters are positive, the underlying business profitability and federal illegality of cannabis remain significant headwinds. A 'hold' recommendation is appropriate for investors monitoring the company's restructuring efforts, but significant risks persist.

Keywords

Cannabis, Multi-state operator, MSO, SEC filing, 10-Q, Financial results, Asset sales, Debt restructuring, Legal proceedings, Going concern, Marijuana, Cultivation, Dispensary